Back To Top

Tip: To quickly find your search term on this page, press "Ctrl" + "f" on your keyboard (Command + "f" on a Mac) and use the find bar.
TAK-441 Catalog#: A-1172
         TAK441 is a Hedgehog inhibitor.
TAK-632 Catalog#: A-1297
         TAK-632 is a potent pan-RAF inhibitor with favorable in vitro activity (BRAF(V600E) IC50, 2.4 nM; BRAF(wt), 8.3 nM; CRAF, 1.4 nM; pMEK (A375) IC50, 12 nM; pMEK (HMVII), 49 nM; V/B ratio.
TAK-659 Catalog#: A-6090
         TAK-659 is a selective SYK inhibitor.
TAK-700 Catalog#: A-1193
         TAK-700 is an oral, selective, non-steroidal androgen synthesis inhibitor of the 17,20 lyase in clinical trials.
TAK-733 Catalog#: A-1225
         TAK-733 is an MEK inhibitor in clinical trials.
TAK-960 Catalog#: A-1264
         TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1
TAK438 Catalog#: A-9061
         TAK438; TAK-438; TAK 438
Talarozole Catalog#: A-1212
         Talarozole is a Cyp26 inhibitor in clinical trials.
Talmapimod(SCIO-469) Catalog#: A-1922
Tamoxifen Citrate Catalog#: A-1916
         Tamoxifen Citrate
Tarceva (Erlotinib, OSI-774) Catalog#: A-1048
         Tarceva is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, which was approved for cancer treatment by FDA.
TAS-115 Catalog#: A-1366
TAS-116 Catalog#: A-1924
         TAS-116 is an oral selective HSP90α/β Inhibitor.
TAS-121 Catalog#: A-1390
         TAS-121 is an EGFR tyrosine kinase inhibitor.
Taxotere Catalog#: A-1218
Telatinib (BAY 57-9352) Catalog#: A-1270
         Telatinib (BAY 57-9352) is a potent inhibitor of VEGFR2, VEGFR3, c-Kit and PDGFRβ with IC50 of 6 nM, 4 nM, 1 nM and 15 nM, respectively.
Temozolomide Catalog#: A-1217
         Temozolomide (brand names Temodar and Temodal) is an oral alkylating agent used for the treatment of Grade IV astrocytoma — an aggressive brain tumor, also known as glioblastoma multiforme — as well as for treating melanoma, a form of skin cancer.
Tetrandrine Catalog#: A-3017
         Tetrandrine is an mTOR inhibitor with anti-cancer activity
TG-101348 Catalog#: A-1140
         TG-101348 is a potent, highly selective JAK2 inhibitor
TG-2 Catalog#: A-1208
         TG-2 is an ERK/Flt3/Jak2 inhibitor in clinical trials.
TGR-1202 (RP-5264) Catalog#: A-1334
         TGR-1202 (RP-5264) is a highly specific, orally available, PI3K delta inhibitor.
TGX-221 Catalog#: A-1050
         TGX-221 is a cell-permeable morpholino-pyrimidinone compound that acts as a reversible, ATP-competitive, selective, and highly potent inhibitor of PI 3-Kb
TKI-258(CHIR-258, Dovitinib) Catalog#: A-1129
         TKI258 is a novel FGFR/PDGFR/VEGFR inhibitor
TL-32711 Catalog#: A-1901
         TL-32711 is a SMAC (second mitochondrial-derived activator of caspases) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family proteins, with potential antineoplastic activity.
TLN-232 Catalog#: A-1326
         TLN-232 is a novel seven amino-acid peptide with potential efficacy in multiple oncology indications that targets pyruvate kinase M2 (M2PK), a protein shown to be over-expressed in a number of different tumour types.
TNF-a Catalog#: A-4005
         Recombinant Human Tumor Necrosis Factor Alpha
Topotecan Catalog#: A-2010
         Topotecan hydrochloride (trade name Hycamtin) is a chemotherapy agent that is a topoisomerase I inhibitor
Toremifene citrate salt Catalog#: A-1273
         Toremifene citrate is an oral selective estrogen receptor modulator (SERM). Toremifene citrate is used in advanced (metastatic) breast cancer and being evaluated for prevention of prostate cancer.
TRAIL Catalog#: A-4006
         Recombinant Human TRAIL/TNFSF10
Triptolide Catalog#: A-3020
         Inhibits cytokine-induced gene expression via inhibition of NF-κB transcriptional activity.
Tubacin Catalog#: A-1028
         Tubacin is a selective inhibitor of histone deacetylase 6 (HDAC6), a predominantly cytoplasmic class II histone deacetylase that is involved in many cellular processes, including degradation of misfolded proteins, cell migration, and cell-cell interaction. Tubacin selectively inhibit HDAC6-mediated alpha -tubulin deacetylation.
Tubastatin A Catalog#: A-1159
         Tubastatin A is a potent and selective HDAC6 (histone deacetylase 6) inhibitor.
TX1-85-1 Catalog#: A-6105
         TX1-85-1 is a selective Her3 inhibitor.

*Note: These products are for research purposes only, not for human consumption.